Stefano Luminari, MD¹, Luca Guerra, MD^2*, Carla Minoia, PhD^3*, Stephane Chauvie, PhD^4*, Antonella Anastasia^5*, Federica Cavallo, MD^6*, Paolo Corradini, MD⁷, Sara Rattotti^8*, Rexhep Durmo^9*, Chiara Ghiggi, MD^10*, Jacopo Olivieri, MD^11*, Simone Ferrero, MD¹², Gloria Margiotta Casaluci, MD^13*, Luca Nassi, MD^14*, Caterina Stelitano^15*, Francesca Ricci, MD^16*, Vittorio Ruggero Zilioli, MD^17*, Antonio Pinto, MD^18,19*, Manuela Zanni, MD, PhD^20*, Bolis Silvia, MD^21*, Caterina Patti, MD^22*, Michele Merli, MD^23,24*, Annalisa Chiarenza^25*, Gerardo Musuraca, MD, PhD^26*, Patrizia Tosi, MD^27*, Massimo Federico, MD²⁸ and Annibale Versari, MD^29*

¹Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, REGGIO EMILIA, Italy
²Nuclear Medicine, University of Milan Bicocca, Monza, Monza, Italy
³Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
⁴Medical Phyhsics Department, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
⁵Hematology, ASST Spedali Civili, Brescia, Italy
⁶Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Turin, Italy
⁷Università degli Studi di Milano and Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCSS) Istituto Nazionale dei Tumori, Milan, Italy
⁸Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁹Nuclear Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Italy, Reggio Emilia, Italy
¹⁰Hematology unit IRCCS Policlinico San Martino, Genova, Italy
¹¹SOC Clinica Ematologica, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, Italy
¹²Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy
¹³Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
¹⁴Department of Hematology, AOU Careggi, Florence, Italy
¹⁵Division of Hematology, Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria, Italy
¹⁶Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy
¹⁷Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
¹⁸Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", Napoli, Italy
¹⁹Hematology-Oncology & Stem Cell Transplantation Unit, National Cancer Institute, Fondazione Pascale, IRCCS, Naples, Italy
²⁰Hematology, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
²¹Hematology, S. Gerardo University Hospital, ASST Monza, Monza, Italy
²²Division of Hematology, A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
²³Hematology, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
²⁴Division of Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi, University of Insubria, Varese, Italy
²⁵Divisione di Ematologia, Ospedale Ferrarotto, A.O.U. Policlinico-OVE, Università di Catania, Catania, Italy
²⁶Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
²⁷Hematology Unit, Infermi Hospital Rimini, Rimini, Italy
²⁸CHIMOMO department, Università degli Studi di Modena e Reggio Emilia, Modena, Italy
²⁹Nuclear Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

Maare Arffman, MSc^1,2*, Leo Meriranta, MD^1,2*, Harald Holte, MD, PhD^3,4, Judit Jørgensen, MD, PhD^5*, Peter De Nully Brown, MD⁶, Sirkku Jyrkkio, MD, PhD^7*, Mats Jerkeman, MD, PhD⁸, Øystein Fluge, MD, PhD^9*, Magnus Björkholm, MD, PhD¹⁰, Matias Autio^1,2*, Suvi-Katri Leivonen, PhD^1,2 and Sirpa Leppa, MD, PhD^1,2

¹Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
²Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland
³KG. Jebsen Centre for B cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway
⁴Department of Oncology, Oslo University Hospital, Oslo, Norway
⁵Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁶Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
⁷Turku University Hospital, Turku, Finland
⁸Skane University Hospital and Lund University, Lund, Skaane Laen, Sweden
⁹Haukeland University Hospital, Bergen, Norway
¹⁰Department of Medicine, Karolinska University Hospital, Stockholm, Sweden

Andrea Garofalo^1*, Stefan K. Alig, MD², Joseph Schroers-Martin, MD³, Ragini Malika Shyam, MD^4*, Mari Olsen^2*, David M. Kurtz, MD, PhD^5,6, Cédric Rossi, MD, PhD^7*, Andre Schultz, PhD^8*, Karan R. Kathuria^2*, Chih Long Liu, PhD^9*, Valeria Spina^10*, Jamie E. Flerlage, MD, MS¹¹, Sharon M. Castellino, MD, MSc¹², Ranjana H. Advani, MD¹³, Davide Rossi, MD, PhD¹⁴, Ryan C. Lynch, MD¹⁵, Olivier Casasnovas, MD^7*, Lianna J. Marks, MD¹⁶, Michael P. Link, MD¹⁷, Marc Andre, MD^18*, Peter Vandenberghe, MD, PhD¹⁹, Christian Steidl^20*, Maximilian Diehn, MD, PhD^21* and Ash A. Alizadeh, MD, PhD²²

¹Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA
²Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
³Stanford University, Stanford, CA
⁴Stanford University Cancer Center, Los Altos, CA
⁵Department of Medicine, Divisions of Hematology & Oncology, Stanford University, Stanford, CA
⁶Stanford University, Palo Alto, CA
⁷Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France
⁸Foresight Diagnostics, Aurora, CO
⁹Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
¹⁰Institute of Oncology Research, Bellinzona, Switzerland
¹¹Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
¹²Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA
¹³Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
¹⁴Amedeo Avorgadro Univ. of Eastern Piedmont, Bellinzona, Italy
¹⁵Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁶Department of Pediatrics, Stanford University, Stanford, CA
¹⁷Department of Pediatrics, Stanford University, Palo Alto, CA
¹⁸Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
¹⁹University of Leuven, Leuven, Belgium
²⁰Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
²¹Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
²²Department of Medicine, Divisions of Hematology & Oncology, Stanford University Medical Center, Stanford, CA

Nitin Agarwal, PhD^1*, Akanksha Aradhya^1*, Mario L. Marques-Piubelli, MD^2*, Luisa M Solis Soto, MD^2*, Daniel Bilbao, PhD³, Ralf Landgraf, PhD^4*, Vida Ravanmehr^5*, Jared Henderson, PhD^5*, Michael R. Green, PhD⁵, Eric Davis, MD^5* and Francisco Vega, MD, PhD¹

¹Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Miami, Miami, FL
⁴Department of Biochemistry and Molecular Biology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL
⁵Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Nicolas Di Siervi, PhD¹, Maria Victoria Revuelta, PhD^1*, Maria Teresa Cacciapuoti^2*, Nahuel Zamponi, PhD², Rossella Marullo, MD, PhD³, Ari Melnick, MD⁴, Giorgio Inghirami, MD^5* and Leandro Cerchietti, MD⁶

¹Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY
²Weill Cornell Medicine, New York, NY
³Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
⁴Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
⁵Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
⁶Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY

Ferran Araujo-Ayala^1,2*, Cèlia Dobaño-López, MSc^1,2*, Juan G Valero, PhD^1,2*, Ferran Nadeu, PhD^1,2*, Fabien Gava, PhD^3*, Carla Faria, PhD^3*, Marine Norlund, PhD^4*, Renaud Morin, PhD^4*, Pascale Bernes-Lasserre^4*, Neus Serrat, MD, PhD^1*, Heribert Playa-Albinyana, MSc, BSc^1,2,5*, Rubén Giménez, MSc^1,2*, Elías Campo, PhD MD^1,2,5,6, Jean Michel Lagarde, PhD^4*, Armando López-Guillermo, MD, PhD^1,2,5,7*, Eva Giné, MD, PhD^1,2,7, Dolors Colomer, PhD^1,2,5,6*, Christine Bezombes, PhD^3* and Patricia Pérez-Galán, PhD^1,2*

¹Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
²Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
³Centre de Recherches en Cancérologie de Toulouse, INSERM, Toulouse, France
⁴IMACTIV-3D, Toulouse, France
⁵University of Barcelona, Barcelona, Spain
⁶Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain
⁷Hematology Department, Hospital Clínic, Barcelona, Spain